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1. Introduction  
Allergic airway inflammation is one characteristic feature of asthma disease, with additional 
pathology including a reversible airway obstruction, airway hyperresponsiveness (AHR), 
infiltration of eosinophils and T-helper type 2 (Th2) cells into the airway submucosa, mucus 
hypersecretion, and airway remodeling (Agrawal & Shao 2010). Allergic airway diseases are 
inflammatory disorders in which aberrant immune regulation occurs and susceptible 
individuals mount allergen specific responses. Inflammatory cells are recruited to the 
asthmatic airways or are activated in situ. The inflammatory cells include mast cells, 
macrophages, eosinophils, T lymphocytes, dendritic cells, basophils, neutrophils, and 
platelets (Barnes et al. 1998). Structural cells may also be important sources of inflammatory 
mediators in asthma. Airway epithelial cells, smooth muscle cells, endothelial cells, and 
fibroblasts are all capable of synthesizing and releasing inflammatory mediators (Levine, 
1995; Saunders et al. 1997; John et al. 1997). Moreover, these cells may become the major 
source of inflammatory mediators in the airway, which may explain how asthmatic 
inflammation persists even in the absence of activating stimuli. A majority of patients with 
asthma have an atopic, allergic background (Robinson 2000). The prevailing consensus in 
regards to these patients is that the immunological basis of atopic sensitization and allergic 
disease results from inappropriate Th2 cell responses to common environmental proteins 
termed allergens (Robinson 2009). 
Here, we summarize recent findings regarding how immune response and inflammatory 
cells contribute to allergic airway inflammation and discuss recent progress in the regulation 
of these cells. 
2. Immune mechanism 
In general, airway inflammation involves the activation of pathogenic-specific inflammatory 
cells, modulation of transcription factors and release of inflammatory mediators (Barnes et 
al. 1998). Allergic asthma, classified as a type 1 hypersensitivity reaction, involves allergen-
specific immunoglobulins of the IgE class bound to high-affinity Fcε receptors (FceR) on the 
surface of basophils and mast cells present in the subepithelial layer of the airways. Cross-
linking of the receptor initiates a coordinated sequence of biochemical and morphological 
events that results in exocytosis (figure 1) of secretory granules containing histamine or 
other pre-formed inflammatory mediators; synthesis and secretion of newly formed lipid 
mediators, such as prostaglandins and leukotrienes; and synthesis and secretion of 
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cytokines (Will-Karp et al. 1999). Many mediators are released in asthma, and it is clear that 
these mediators interact with each other in some way. Mediators may act synergistically to 
enhance each other’s effects, or one mediator may modify the release or action of another 
mediator. Although the involved signaling pathways have been extensively studied, the 
precise sequence of events is still not well understood (Turner et al. 1999; Kim et al. 1997; 
Ali., et al. 2001; Ching et al., 2001; Siraganian 2003; Galli et al. 2008; Kim et al. 2008; Saini et 
al. 2009; Moran et al. 2010a,b; Colgan & Hankel 2010). The inflammatory mediators are 
capable of contracting airway smooth muscle cells, inducing edema and mucus secretion, 
which leads to narrowed, constricted airways. Furthermore, locally produced chemokines 
stimulate the recruitment of eosinophils, macrophages, neutrophils, and T lymphocytes 
(Broide 2001). 
 
Preformed mediators
Histamine
Serotonin
Kalikreins
Proteases
Proteoglycans
Lipid mediators
PGD2
LTC4
LTB4
TXA2
PAF
Cytokine synthesis
and secretion
IL-1ǂ
IL-4
IL-5
IL-6
IL-8
IL-13
TNF- ǂ
Neutral proteases
Tryptase
Cathepsin G
Carboxypeptidase
Growth factors
FGP
VEGF
Chemokines
MIP-1ǂ, MCP-1
MIP-1B, RANTES
 
Fig. 1. Products of Mast Cells. PGD2, prostaglandin D2; LTC4, leukotriene C4; PAF, platelet-
activating factor; FGP, fibroblast growth factor; VEGF, vascular endothelial growth factor, 
MIP; macrophage inflammatory protein; RANTES, regulated on activation, normal T-cell 
expressed and secreted MCP-1, monocyte chemotactic protein-1. 
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2.1 Role of T cells in airways allergy disease 
T cells play an important role in the modulation of the immune response and are critical 
during allergy airway pathogenesis. Since 1986, the Th1/Th2 paradigm has dominated the 
understanding of the pathophysiology of asthma and allergic disease (Akbari et al. 2003). It 
is generally accepted that allergic respiratory disease in adults is associated with active T-
cell immune responses to inhaled allergens that are skewed toward the Th2 phenotype, 
which is in contrast to a Th1-skewed immunity in healthy individuals (Agrawal and Shao 
2010). Experimental animals model have been useful in the immunological delineation of 
the role of T cells and T cell-derived cytokines in the pathogenesis of airway allergy disease. 
In these animal models, sensitization with various allergens, such as ovalbumin, house dust 
mite, and aspergillus, induce a phenotype closely resembling that observed in human 
asthma (Hausding et al. 2008; Humar et al. 2008; Allen 2009; Bates et al. 2009; Qarcoo et al. 
2009; Moran & Folch 2011).  
Th2-associated cytokines such as IL-4 are important in driving IgE production to allergens 
and are essential in the initiation of an allergic airway response (Coyle et al. 1995). IL-5 
contributes to the development, recruitment and activation of eosinophils at the site of the 
Th2 inflammatory response, which characterizes allergic disease. IL-9 is an important 
regulator of mast-cell activation.  Studies suggest that IL-13 has an important role in the 
effector phase of the allergy response, specifically airway inflammation, bronchial 
hyperresponsiveness and mucus cell hypersecretion (Wills-Karps et al. 1998; Wills-Karps et 
al. 1999 ). The involvement of each the specific Th2 cytokines in atopic airway response has 
been demonstrated in studies in which IL-4, IL-5, IL-9 and IL-13 have been manipulated 
through either antibody blockade (Kung et al. 1995; Gavet et al. 1997) or gene targeting 
(Brusselle et al. 1995; Foster et al. 1996; Spergel et al. 1999). Additionally, IL-21 has been 
shown to be important in the development of Th2 immune response (Frohlich et al. 2007). 
Frohlich and colleagues (2007) suggest that although the mechanisms by which IL-21 
regulates allergy inflammation are unknown, IL-21 may be important for Th2-cell survival 
or migration to peripheral tissues. On the other hand, Th1 cells are also pro-inflammatory, 
and the development of a Th1-associated inflammatory response can exacerbate asthma and 
allergic disease. IFN-Ǆ is often present at sites of allergic inflammation and is thought to 
contribute to the disease. Th1 cells cross-regulate Th2 cells in some systems, and it was 
thought that Th1 cells downmodulated the effects of Th2 cells. However, recent advances in 
immunology have raised the possibility that other mechanisms may drive or co-exist with 
pathology in some patients with Th2-type allergy airway inflammation. New effector T-cell 
lineages have recently been identified. Th17 cells, which differentiate from naïve CD4+ T 
cells under the influence of IL-6/IL-21/IL-23 and transforming growth factor (TGF)-ǃ via 
the signal transducer and activator of transcription 3 (STAT3)-RORǄt pathway, are mainly 
responsible for neutrophilia in allergic severe asthma (Louten et al. 2009). Moreover, a 
variety of cytokines derived from epithelium, fibroblasts and other airway structural cells 
have recently been shown to have an important potential for interaction with Th1, Th2, 
Th17, eosinophil and mast cells.  These cytokines include the following: proinflammatory 
cytokines [IL-1ǃ, IL-6, IL-11, tumor necrosis factor (TNF)-ǂ, and granulocyte/macrophage 
colony–stimulating factor (GMCSF)], which are involved in innate host defense; anti-
inflammatory cytokines [IL-10, IFN-Ǆ, IL-12, and IL-18]; growth factors [platelet derived 
growth factor (PDGF), TGF-ǃ, fibroblast growth factor (FGF), and epidermal growth factor 
(EGF)]; and chemotactic cytokines or chemokines [RANTES, monocyte chemoattractant 
protein (MCP)-1–MCP-5, eotaxin, and IL-8] (Hamid and Tulic 2009). 
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Conversely, investigations into the contribution of cytotoxic CD8+ T cells towards the 
development of allergic airway inflammation are not well understood. The depletion of 
CD8+ T cells does not affect airway response to allergen challenge in mice (Gonzalo et al. 
1996).  However, a subset of CD8+ T cells, named Tc2 cells, can produce Th2 cytokines such 
as IL-4, IL-5, and IL-13, which are increased in the bronchoalveolar lavage fluids (BALF) of 
allergic asthmatic patients in studies. This rise of cytokine production suggests that the 
immune responses to virus infections are characterized by an increase in the frequency of 
type 2 cytokine-producing T cells when they take place in an allergic environment in animal 
models (Coyle et al. 1995; Makela et al. 2003). Human studies show that CD8+ T cells from 
both normal and asthmatic subjects have the capacity to produce type 2 cytokines (Stanciu 
et al. 1996; Stanciu et al. 1997). In addition, the stimulation of CD8+ T cells from normal, 
healthy subjects in an IL-4 rich milieu significantly increased the number of IL-5-positive 
CD8+ T cells (Stanciu et al. 2001). Additionally, studies suggest that during a respiratory 
virus infection activated CD8+ T cells from asthmatic subjects may produce excess type 2 
cytokines and may contribute to asthma exacerbation by augmenting allergic inflammation 
(Stanciu et al. 2005). These studies thus demonstrate that the frequency of airway CD8+ T 
cells producing type 2 cytokines are as great as those of airway CD4+ T cells are and that 
both are increased in asthma and are related to disease severity (Cho et al. 2005).  
2.1.1 Transcription factors responsible for the Th1/Th2/Th17 cells and inflammatory 
mediators 
Transcription factors are DNA-binding proteins that regulate the expression of inflammatory 
genes, including enzymes involved in the synthesis of inflammatory mediators as well as 
protein and peptide mediators (Barnes et al. 1998). Inflammation associated with 
hypersensitivity results from an exaggerated expression of inflammatory genes, and a number 
of researchers have explored the mechanisms implicated in inflammatory gene induction 
(Barnes and Karin, 1997; Barnes and Adcock, 1998). Many transcription factors are cell-specific 
and are crucial in cell differentiation and the regulation of specific cellular processes such as 
proliferation, enzymes, and cytokine expression. In animal models of airway diseases, such as 
atopic asthma, nuclear factor NF-(kB), activator protein-1 (AP-1), GATA-3, JunB and c-Maf 
play a central role in the control of airway inflammation (Finotto et al. 2001; Nguyen et al. 
2003; Yamashita et al. 2007). In humans, there is evidence that NF-kB, AP-1 and GATA-3 
expression is increased in asthmatic airways (Hart et al., 1998; Taha et al. 2003). Furthermore, 
these transcription factors are key downstream regulators of Th1/Th2/Th17 cytokine function 
and are phosphorylated/dephosphorylated in the asthmatic airway (Pernis and Rothman, 
2002). The Th1 master regulator, T-box transcription factor (T-bet), is extensively expressed 
in polarized Th1 cells, and its expression and activity are induced by IL-12 via STAT4 or by 
IFN-Ǆ via STAT1.  IL-4 drives differentiation of IL-4-producing Th2 cells through STAT6, 
which is necessary and sufficient for the induction of the Th2 master regulator, GATA-3. 
Moreover, transcription factor c-Maf is selectively expressed in Th2 cells as a downstream 
effector of the IL-4/IL-4R/STAT6 signal transduction pathway, primarily regulating IL-4 
expression in Th2 cells (Agrawal & Shao 2010). 
2.1.2 Role of regulatory T cells in allergy airway diseases 
As mentioned previously, allergic airway diseases show complex genetic associations and 
have a hereditary component (Cookson & Moffat 2004). However, the rapid and 
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geographically localized nature of the increase in the incidence of allergic diseases indicates 
compounding effects of recent changes in environment and lifestyle in the Western world. 
How these factors impact disease by promoting immune responses to allergens is a subject 
of considerable debate, which has led to the “hygiene hypothesis” (Wills-Karp et al. 2001; 
Liu & Murphy 2003). According to the theory, in its simplest iteration, the increase in 
hygienic living conditions and in the use of antibiotic and sterile food preparations resulted 
in the separation of the immune system from positive microbial exposure early in life 
(Martinez and Holt, 1999). The immunoregulatory mechanisms remain underdeveloped, 
and an imbalance in immune homeostasis predisposes to the development of T helper type 
2-biased immune responses and, consequently, allergic disease (Feleszko et al. 2005). 
Recent studies indicate that Th2 responses that are characteristic of allergic manifestations 
can be regulated by naturally occurring CD4+CD25+ regulatory T (nTreg) cells. These cells 
are a functionally mature T-cell subpopulation, which play key roles in the maintenance of 
immunologic self-tolerance and negative control of a variety of physiological and 
pathological immune responses (Sakagushi et al. 2006). They also constitutively express 
transcription factor forkhead box P3 (FoxP3), which prevents the deviation of Tregs into 
effector T cells (Burchill et al. 2007). These cells originate in the thymus, but inducible Treg 
(iTreg) cells, which have similar properties and characteristics, can also be induced in the 
periphery. Regulatory T cells appear to control the development of autoimmune disease and 
transplant rejection and may play a critical role in controlling asthma and allergy (Akdis et 
al. 2005).  Several studies indicate that the function of naturally occurring Treg cells is 
impaired or altered in patients with allergies compared with normal healthy individuals. 
The adoptive transfer of antigen-specific CD4+CD25+ T-regs attenuates acute allergic 
airway inflammation, AHR, and airway remodeling. The capacity of Treg cells to inhibit the 
proliferation of naive T cells in vitro requires cell–cell contact (induction of an inhibitory 
signals on CD4+ and CD8+ T cells); however, in vivo, these cells can also function through 
induction of inhibitory cytokines (such as TGF-ǃ and IL-10) and inhibition of antigen-
presenting capacity (Zheng et al. 2006; Kearly et al. 2008). These data suggest that one 
potential treatment option would be to enhance CD4+CD25+ Tregs in addition to targeting 
decreased Th2 populations. An example of this therapeutic strategy would be allergen 
desensitization immunotherapy, which has been in use for almost a century and is one of 
the few specific immunomodulatory treatments that are commonly used for allergic asthma 
(Akbari et al. 2003; Kearly et al. 2008). Understanding the immune mechanisms that underlie 
successful allergen immunotherapy offers the potential to improve current allergen-
immunotherapy regimens. Some authors suggest that this therapy might function, at least in 
part, to promote the generation of IL-10 and TGF-ǃ-secreting regulatory T cells 
(Hawrylowicz & Garra 2005; Shevach et al. 2008). 
3. Apoptosis regulation in allergy airway disease 
Apoptosis is defined as a genetic program that eliminates unneeded, senescent, or damaged 
cells (Thompson 1995). Moreover, apoptosis is an important regulatory mechanism in the 
selection and containment of an immunocompetent T cell population, in T cell development 
and during immune responses. Dysregulation of apoptosis has been implicated in a range of 
diseases including tumors, neurodegenerative disorders, autoimmunity (Cohen 1999) and, 
perhaps, allergic asthma (Vignola et al. 1999; Woolley et al. 1996). Studies in human patients 
have demonstrated that reduced T cell apoptosis plays an important role in the pathogenesis 
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of allergic bronchial asthma (Cormican et al. 2001; Vignola et al. 1999; De Rose et al. 2004). 
These findings are also consistent in murine models of asthma (Jayaraman et al. 1999; Tong 
et al. 2006; Finotto et al. 2007). In addition, increasing lines of evidence suggest that changes 
in programmed cell death mechanisms in both mobile and resident cells of the airway may 
directly contribute to the development and clinical severity of allergy airway inflammation 
(Vignola et al. 2000). 
Apoptosis has emerged as a major mechanism in the clearance of activated T cells during 
the resolution of an inflammatory response (Akbar and Salmon 1997). Inadequate T cell 
apoptosis in asthma patients appears to interfere with normal T cell elimination, resulting in 
T cell accumulation, which contributes to chronic inflammation and may be the major 
underlying cause for tissue damage, remodeling and repair (Müller et al. 2006; Vignola et al. 
2000). Spinozzi et al. (1998) reported that pulmonary T cells isolated from the BALF of atopic 
asthma patients showed hypoexpression of Fas and FasL; this result may explain the low 
frequency of apoptosis in this group of patients. In contrast, horses with acute airway 
allergy have increased apoptosis of airway lymphocytes, which may partially explain the 
rapid resolution of the pathology once the allergen is removed in this allergy model (Moran 
et al. 2011). However, these authors suggest additional studies to examine apoptosis and 
cytokine profiles in other stages of the disease. In addition, basal levels of apoptotic activity 
were significantly lower in BALF lymphocytes from asthmatic subjects compared with 
peripheral blood lymphocytes from the same subjects. These data indicate that airway 
inflammation in asthma is associated with a reduced susceptibility to apoptosis, which may 
lead to enhanced survival of lymphocytes in the bronchial mucosa and prolonged 
inflammation (Müller et al. 2006). Other molecules are involved in the programmed cell 
death process, including members of the Bcl-2 gene family, which are known to inhibit 
apoptosis. Studies have shown that Bcl-2 expression is increased in lymphoid cells obtained 
from the airways of asthmatic patients and that neutralization of IL-10, an important 
inducer of Bcl-2, decreases Bcl-2 expression and apoptosis of cells from the respiratory tract 
of asthmatic patients (Hamzaoui et al. 1999a; Hamzaoui et al. 1999b). 
4. Airway remodeling 
Recently, airway remodeling has become a field of special interest in chronic asthma, 
chronic bronchitis, chronic obstructive pulmonary disease (COPD) and cystic fibrosis 
research as the process that causes patients to become largely resistant to medication and is 
an important factor in the development of irreversible airflow limitation (James et al., 1989; 
Lange et al., 1998; Jeffery et al., 2000; Kranenburg et al., 2002 Wegmann, 2008). In tissues 
from human with these diseases, remodeling changes include goblet cell and mucous gland 
hyperplasia, subepithelial fibrosis, neovascularization, airway smooth muscle (ASM) 
growth as well as increased deposition of extracellular matrix (ECM) proteins such as 
collagens, elastin, laminin, and  proteoglycans around  the smooth muscle and an overall 
thickening of the airway wall (Roche et al 1989; Laitinen et al., 1997; Davies et al., 2003). The 
molecular mechanisms that drive remodeling remain undefined, but many growth factors 
and cytokines, including fibroblast growth factor (FGF)-1, FGF-2, and transforming growth 
factor (TGF)-ǃ1, that are released from  the airway wall have the potential to contribute to 
airway remodeling, revealed by enhanced ASM proliferation and increased ECM protein 
deposition (Parameswaran et al., 2006; Kariyawasam and Robinson 2007).  TGF-ǃ1 is an 
important fibroblast chemotactic factor. Fibroblast numbers have been shown to correlate 
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with TGF-ǃ1 expression. TGF-ǃ1 also induces the differentiation of fibroblasts to 
myofibroblasts (Postlethwaite and Seyer, 1995; Vignola et al., 1997; Thannickal et al., 2003). 
Morover, TGF-ǃ1 and FGF-1 stimulate mRNA expression of collagen I and III in ASM cells, 
suggesting their role in the deposition of extracellular matrix proteins by ASM cells in the 
airways of patients with chronic lung diseases. Furthermore, ECM proteins promote the 
survival, proliferation, cytokine synthesis, migration, and contraction of human ASM cells 
contributing to airway wall remodeling (Parameswaran et al., 2006) 
5. Conclusion  
Asthma allergy disease is multifactorial, characterized by allergy airway inflammation and 
increased bronchoconstrictory response to nonspecific stimuli. The current body of 
knowledge suggests that the inflammatory component of asthma results from a combination 
of elements from both the innate and adaptive immune responses. Expression of cytokine 
patterns consistent with Th1, Th2 and Th17 cell activation has been identified and 
determined to vary based on the chronic condition of the disease. Activation of transcription 
factors plays a pivotal role in regulating cellular signaling pathways through dynamic 
modulation of cytokines, chemokines, and similar molecules. The regulation of the 
apoptosis of inflammatory cells, fibroblasts, and myocytes through Bcl-2 expression 
contributes to the establishment of chronic disease and remodeling. Tregs seem to play a 
pivotal role in balancing tolerance versus immunologic response to allergens. Therapy with 
immunomodulators that enhance tolerance to allergens and increase Tregs would be most 
effective in the treatment of allergy airway disease.  
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